
Rei Tsang Shiao
Examiner (ID: 13461, Phone: (571)272-0707 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9772580
[patent_doc_number] => 20140296244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/182208
[patent_app_country] => US
[patent_app_date] => 2014-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20313
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14182208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/182208 | Method for treating a pulmonary hypertension condition | Feb 16, 2014 | Issued |
Array
(
[id] => 9537714
[patent_doc_number] => 20140162361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/179960
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21684
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179960
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179960 | Pyrimidine cyclohexyl glucocorticoid receptor modulators | Feb 12, 2014 | Issued |
Array
(
[id] => 9721111
[patent_doc_number] => 20140256812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'NOVEL ANTIMICROBIAL COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/179286
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13040
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179286 | Antimicrobial compounds and uses thereof | Feb 11, 2014 | Issued |
Array
(
[id] => 9562001
[patent_doc_number] => 20140179714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/177469
[patent_app_country] => US
[patent_app_date] => 2014-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26289
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14177469
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/177469 | Compounds | Feb 10, 2014 | Issued |
Array
(
[id] => 9491659
[patent_doc_number] => 20140142064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'BORON-CONTAINING SMALL MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/165428
[patent_app_country] => US
[patent_app_date] => 2014-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34968
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14165428
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/165428 | BORON-CONTAINING SMALL MOLECULES | Jan 26, 2014 | Abandoned |
Array
(
[id] => 9603535
[patent_doc_number] => 20140200217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'SMOOTHENED ANTAGONISM FOR THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/163453
[patent_app_country] => US
[patent_app_date] => 2014-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23036
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14163453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/163453 | SMOOTHENED ANTAGONISM FOR THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS | Jan 23, 2014 | Abandoned |
Array
(
[id] => 9450097
[patent_doc_number] => 20140121267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/148572
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22147
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148572
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148572 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | Jan 5, 2014 | Abandoned |
Array
(
[id] => 9491771
[patent_doc_number] => 20140142178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/148580
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20306
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148580
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148580 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | Jan 5, 2014 | Abandoned |
Array
(
[id] => 11893982
[patent_doc_number] => 09763900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Chemical chaperonins as novel molecular modulators of beta protein aggregation present in conformational diseases'
[patent_app_type] => utility
[patent_app_number] => 14/771144
[patent_app_country] => US
[patent_app_date] => 2013-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10081
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771144
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771144 | Chemical chaperonins as novel molecular modulators of beta protein aggregation present in conformational diseases | Dec 29, 2013 | Issued |
| 14/137212 | Pyrimidinones as Casein Kinase II (CK2) Modulators | Dec 19, 2013 | Abandoned |
Array
(
[id] => 9561949
[patent_doc_number] => 20140179663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/135812
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14592
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14135812
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/135812 | Apoptosis signal-regulating kinase inhibitors | Dec 19, 2013 | Issued |
Array
(
[id] => 9989629
[patent_doc_number] => 09034833
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-05-19
[patent_title] => 'Anti-aging composition containing high levels of a jasmonic acid derivative'
[patent_app_type] => utility
[patent_app_number] => 14/136471
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5784
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14136471
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/136471 | Anti-aging composition containing high levels of a jasmonic acid derivative | Dec 19, 2013 | Issued |
Array
(
[id] => 9771886
[patent_doc_number] => 20140295549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS BY STIMULATING ER STRESS'
[patent_app_type] => utility
[patent_app_number] => 14/109731
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18306
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109731
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/109731 | METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS BY STIMULATING ER STRESS | Dec 16, 2013 | Abandoned |
Array
(
[id] => 9971233
[patent_doc_number] => 09018243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/102407
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 31121
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14102407
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/102407 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | Dec 9, 2013 | Issued |
Array
(
[id] => 11407835
[patent_doc_number] => 09555121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex'
[patent_app_type] => utility
[patent_app_number] => 14/650660
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6477
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650660 | Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex | Dec 9, 2013 | Issued |
Array
(
[id] => 9518936
[patent_doc_number] => 20140155428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/097693
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62723
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14097693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/097693 | Compounds | Dec 4, 2013 | Issued |
Array
(
[id] => 9538435
[patent_doc_number] => 20140163081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'LXR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/085926
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25062
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085926
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/085926 | LXR MODULATORS | Nov 20, 2013 | Abandoned |
Array
(
[id] => 10129200
[patent_doc_number] => 09163027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival'
[patent_app_type] => utility
[patent_app_number] => 14/085712
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 38522
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085712
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/085712 | Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival | Nov 19, 2013 | Issued |
Array
(
[id] => 10406586
[patent_doc_number] => 20150291596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 14/441762
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36747
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441762
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441762 | ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES | Nov 17, 2013 | Abandoned |
Array
(
[id] => 10784253
[patent_doc_number] => 20160130408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 14/787755
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24918
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787755 | Methods for treating lignocellulosic materials | Nov 5, 2013 | Issued |